Publication | Closed Access

High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus

InflammationMetabolic SyndromeGlucose ToleranceCardiovascular DiseaseDiabetesImmunologyType 2PathologyVascular BiologyDiabetes MellitusHigh Plasma LevelsMicrovascular DysfunctionMedicineAtherosclerosis